|
DNAJC27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.99520433297585E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.758600E-01 |
| Stage1-vs-Stage3 |
2.104100E-02 |
| Stage1-vs-Stage4 |
1.942670E-03 |
| Stage2-vs-Stage3 |
2.326400E-02 |
| Stage2-vs-Stage4 |
1.675620E-03 |
| Stage3-vs-Stage4 |
2.368000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.16559999932642E-08 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
2.385800E-01 |
| Caucasian-vs-Asian |
7.414000E-01 |
| AfricanAmerican-vs-Asian |
3.464000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.140800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
4.84430000002867E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.090000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.518400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.602400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.288600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.803200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.61470000037411E-07 |
| Classical-VS-Follicular |
7.497900E-02 |
| Classical-VS-Other |
5.577600E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.76130000373709E-08 |
| Tall-VS-Other |
2.170400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.965400E-01 |
| Follicular-VS-Normal |
1.6251444634463E-12 |
| Other-VS-Normal |
4.68519999996531E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.399900E-02 |
|
|
